-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In order to meet the needs of future business development and resource integration of the group company, recently, the 27th meeting of the fourth board of directors of Limin Holdings reviewed and approved the "Proposal on the Company's Internal Transfer of Rotor Company Equity and Subsidiary Capital Increase" and decided to provide Subsidiary Suzhou Limin Biotechnology Co.
In order to meet the needs of future business development and resource integration of the group company, recently, the 27th meeting of the fourth board of directors of Limin Holdings reviewed and approved the "Proposal on the Company's Internal Transfer of Rotor Company Equity and Subsidiary Capital Increase" and decided to provide Subsidiary Suzhou Limin Biotechnology Co.
This transaction is between 100% directly controlled parent and subsidiary companies, and the parent company transfers its equity to the subsidiary based on the net book value
The internal allocation of the equity of the rotor company and the capital increase of its subsidiaries belongs to the adjustment of the equity structure of the subsidiary within the scope of the company’s consolidated statement.
